BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium

被引：0
|
作者：
Severson, Tesa [1 ]
Peeters, Justine [2 ]
Majewski, Ian [1 ]
Bosma, Astrid [1 ]
Chin, Suet-Feung [3 ]
Caldas, Carlos [3 ]
Simon, Iris [2 ]
Bernards, Rene [1 ]
Linn, Sabine [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Agendia, Amsterdam, Netherlands
[3] Canc Res UK Cambridge Res Inst, Cambridge, England
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4022
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Dominik Glodzik
    Ana Bosch
    Johan Hartman
    Mattias Aine
    Johan Vallon-Christersson
    Christel Reuterswärd
    Anna Karlsson
    Shamik Mitra
    Emma Niméus
    Karolina Holm
    Jari Häkkinen
    Cecilia Hegardt
    Lao H. Saal
    Christer Larsson
    Martin Malmberg
    Lisa Rydén
    Anna Ehinger
    Niklas Loman
    Anders Kvist
    Hans Ehrencrona
    Serena Nik-Zainal
    Åke Borg
    Johan Staaf
    [J]. Nature Communications, 11
  • [22] PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers
    Stebbing, Justin
    Ellis, Paul
    Tutt, Andrew
    [J]. FUTURE ONCOLOGY, 2010, 6 (04) : 485 - 486
  • [23] Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
    Evans, D. G.
    Howell, A.
    Ward, D.
    Lalloo, F.
    Jones, J. L.
    Eccles, D. M.
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 (08) : 520 - 522
  • [24] BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy
    Choi, Eun
    Mun, Gil-im
    Lee, Joohyun
    Lee, Hanhee
    Cho, Jaeho
    Lee, Yun-Sil
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
  • [25] Evaluation of BRCA1 mutations in patients with triple negative breast cancer
    Ellsworth, Rachel E.
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    [J]. CANCER RESEARCH, 2012, 72
  • [26] Prevalence of BRCA1 mutations in triple negative breast cancer (BC).
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Collins, L.
    Schnitt, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Garber, J. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
  • [27] BRCA1 mutation in the Triple- Negative Breast Cancer Group
    Jelena Maksimenko
    Arvids Irmejs
    Genadijs Trofimovics
    Edvins Miklasevics
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
  • [28] BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
    Blanchard, Zannel
    Paul, Bibbin T.
    Craft, Barbara
    ElShamy, Wael M.
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [29] BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
    Zannel Blanchard
    Bibbin T Paul
    Barbara Craft
    Wael M ElShamy
    [J]. Breast Cancer Research, 17
  • [30] A clinically relevant gene signature in triple negative and basal-like breast cancer
    Achim Rody
    Thomas Karn
    Cornelia Liedtke
    Lajos Pusztai
    Eugen Ruckhaeberle
    Lars Hanker
    Regine Gaetje
    Christine Solbach
    Andre Ahr
    Dirk Metzler
    Marcus Schmidt
    Volkmar Müller
    Uwe Holtrich
    Manfred Kaufmann
    [J]. Breast Cancer Research, 13
12345